EXAS - Exact Sciences Corp.
IEX Last Trade
61.71
-0.550 -0.891%
Share volume: 2,201,046
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$62.26
-0.55
-0.88%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-11-03 | 2023-02-21 | 2023-05-09 | 2023-08-01 | 2023-11-01 | 2024-02-21 | 2024-05-08 | 2024-07-31 | |
Total revenue | 523.073 M | 552.995 M | 602.450 M | 622.093 M | 628.338 M | 646.885 M | 637.524 M | 699.264 M | |
Cost of revenue | 147.937 M | 147.152 M | 156.866 M | 156.991 M | 168.526 M | 171.865 M | 170.101 M | 189.848 M | |
Gross profit | 375.136 M | 405.843 M | 445.584 M | 465.102 M | 459.812 M | 475.020 M | 467.423 M | 509.416 M | |
8.19% | 9.79% | 4.38% | -1.14% | 3.31% | -1.60% | 8.98% | |||
Operating expenses | 470.478 M | 498.379 M | 499.678 M | 518.550 M | 501.998 M | 525.950 M | 546.090 M | 508.010 M | |
Selling general and admin | 379.665 M | 404.105 M | 404.259 M | 414.455 M | 390.552 M | 411.028 M | 435.482 M | 387.126 M | |
Research and development | 90.813 M | 94.274 M | 95.419 M | 104.095 M | 111.446 M | 114.922 M | 110.608 M | 120.884 M | |
Total expenses | 641.941 M | 668.445 M | 679.472 M | 698.470 M | 693.516 M | 721.126 M | 739.502 M | 721.169 M | |
4.13% | 1.65% | 2.80% | -0.71% | 3.98% | 2.55% | -2.48% | |||
Operating income | -118.868 M | -115.450 M | -77.022 M | -76.377 M | -65.178 M | -74.241 M | -101.978 M | -21.905 M | |
Ebit | -118.868 M | -115.450 M | -77.022 M | -76.377 M | 6.849 M | -146.268 M | -101.978 M | -21.905 M | |
Pretax income | -151.877 M | -129.927 M | -72.494 M | -79.919 M | 1.043 M | -50.376 M | -108.422 M | -14.345 M | |
-14.45% | -44.20% | 10.24% | -101.31% | -4,929.91% | 115.23% | -86.77% | |||
Income tax | -3.116 M | -2.182 M | 1.657 M | 1.107 M | 249.000 K | -610.000 K | 1.806 M | 1.463 M | |
Net income basic | -148.761 M | -127.745 M | -74.151 M | -81.026 M | 794.000 K | -49.766 M | -110.228 M | -15.808 M | |
14.13% | 41.95% | -9.27% | 100.98% | -6,367.76% | -121.49% | 85.66% | |||
Net income | -148.761 M | -127.745 M | -74.151 M | -81.026 M | 794.000 K | -49.766 M | -110.228 M | -15.808 M | |
14.13% | 41.95% | -9.27% | 100.98% | -6,367.76% | -121.49% | 85.66% |